Filing Details

Accession Number:
0000899243-21-015311
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-07 17:20:12
Reporting Period:
2021-04-05
Accepted Time:
2021-04-07 17:20:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1323113 Jr N Daniel Swisher C/o Corcept Therapeutics Incorporated
149 Commonwealth Drive
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-05 7,500 $6.55 7,500 No 4 M Direct
Common Stock Disposition 2021-04-05 7,500 $24.14 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-04-05 7,500 $0.00 7,500 $6.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,500 2025-06-18 No 4 M Direct
Footnotes
  1. The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.95 to $24.54 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from Issuer upon request.
  3. Fully exercisable.